Sangamo Biosciences reported $334.52M in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Alnylam Pharmaceuticals ALNY:US $ 401.17M 187.04M
Amgen AMGN:US $ 916M 5784M
Avrobio Inc AVRO:US $ 143.16M 26.31M
Bayer BAYN:GR € 37437M 4417M
Biocryst Pharmaceuticals BCRX:US $ -164.22M 57.23M
Biogen BIIB:US $ 11242.3M 346.1M
Biomarin Pharmaceutical BMRN:US $ 4391.31M 120.58M
Bluebird Bio BLUE:US $ 263.26M 111.02M
Gilead Sciences GILD:US $ 19927M 1142M
GlaxoSmithKline GSK:LN 16181M 1126M
Intercept Pharmaceuticals ICPT:US $ -371.76M 187.8M
IONIS PHARMACEUT IONS:US $ 709.57M 62.16M
Johnson & Johnson JNJ:US $ 74709M 686M
Karyopharm Therapeutics KPTI:US $ -83079000 3.41M
Merk MRK:US $ 40883M 2699M
Novartis NOVN:VX SF 61540M 6115M
Omeros OMER:US $ -4925000 28.7M
Pfizer PFE:US $ 82424M 5224M
Regulus Therapeutics RGLS:US $ 49.24M 5.72M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M
Sarepta Therapeutics SRPT:US $ 856.89M 71.12M
Ultragenyx Pharmaceutical RARE:US $ 796.42M 126.14M
Vertex Pharmaceuticals VRTX:US $ 10907M 807M
Ziopharm Oncology ZIOP:US $ 49.12M 8.94M